Myasthenialike syndrome due to adverse effects of cibenzoline in a patient with chronic renal failure.
Wakutani
Y
Y
Matsushima
E
E
Son
A
A
Shimizu
Y
Y
Goto
Y
Y
Ishida
H
H
D000787:Angina Pectoris / Q000150:complications / Q000188:drug therapy*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy*; D004558:Electric Stimulation; D006352:Heart Ventricles; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology*; D009157:Myasthenia Gravis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014459:Ulnar Nerve / Q000187:drug effects / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; C032151:cifenline